Advancing Critical Care: Insights from the LANDI-SEP Study and AI-Driven Optimization of Vasopressin Therapy

Last updated : 31/01/2025 - 2006 views

Advancing Critical Care: Insights from the LANDI-SEP Study and AI-Driven Optimization of Vasopressin Therapy

Replay available

The field of critical care is continuously driven by groundbreaking research and technological innovations. This session highlights two pivotal advancements shaping the future of intensive care:

  • The LANDI-SEP Study: Discover key findings from this multicenter randomised clinical trial, focusing on the use of landiolol for heart rate control in patients with septic shock and persistent tachycardia, and its implications for improved patient outcomes.
  • AI-Driven Optimization of Vasopressin Therapy: Learn how artificial intelligence is revolutionising septic shock management with reinforcement learning to develop optimal vasopressin initiation strategies, enhancing precision and survival rates.

Aims & Objectives

  • Understand the role of landiolol in heart rate control for septic shock patients and its impact as demonstrated in the LANDI-SEP trial.
  • Explore reinforcement learning-driven approaches to determine the optimal initiation of vasopressin therapy in septic shock patients.


Topics & Speakers 

Landiolol for heart rate control in patients with septic shock and persistent tachycardia – A multicenter Randomized Clinical Trial (Landi-SEP)
Sebastian REHBERG
Bethel Protestant Hospital, University Hospital OWL, Bielefeld (DE)

Artificial Intelligence-Derived Optimal Vasopressin Initiation Rule in Patients with Septic Shock. A Reinforcement Learning Study
Romain PIRRACCHIO
University of California San Francisco and Zuckerberg San Francisco General Hospital, San Francisco (US)

MODERATOR

Maria THEODORAKAPOULOU 
KAT General Hospital, Athens (GR)

Thanks to the support of